APA (7th ed.) Citation

Togashi, Y., Nagahashi, M., Oshiro, A., Sugimoto, G., Mitsuyoshi, A., Kanaoka, H., . . . Miyoshi, Y. (2025). Clinical implications of peripheral blood biomarkers in patients with advanced breast cancer treated with trastuzumab emtansine and trastuzumab deruxtecan. International Journal of Clinical Oncology, 1-10. https://doi.org/10.1007/s10147-025-02768-4

Chicago Style (17th ed.) Citation

Togashi, Yusa, et al. "Clinical Implications of Peripheral Blood Biomarkers in Patients with Advanced Breast Cancer Treated with Trastuzumab Emtansine and Trastuzumab Deruxtecan." International Journal of Clinical Oncology 2025: 1-10. https://doi.org/10.1007/s10147-025-02768-4.

MLA (9th ed.) Citation

Togashi, Yusa, et al. "Clinical Implications of Peripheral Blood Biomarkers in Patients with Advanced Breast Cancer Treated with Trastuzumab Emtansine and Trastuzumab Deruxtecan." International Journal of Clinical Oncology, 2025, pp. 1-10, https://doi.org/10.1007/s10147-025-02768-4.